Overview
Livagen is a synthetic tetrapeptide (Lys‑Glu‑Asp‑Ala) studied for its effects on chromatin remodeling and gene expression in aging cells. Research describes activation of ribosomal genes and de‑condensation of heterochromatin in lymphocytes from older individuals.
Key Specifications
| Aspect | Details |
|---|---|
| Vial Size | 20 mg |
| Reconstitution | 3.0 mL bacteriostatic water |
| Concentration | ~6.67 mg/mL |
| Route | Subcutaneous (once daily) |
| Storage (reconstituted) | 2–8 °C (35.6–46.4 °F) |
| Storage (lyophilized) | ~−20 °C (−4 °F) |
Dosing Protocol
Standard Titration Schedule
| Period | Daily Dose | Insulin Units | Volume (mL) |
|---|---|---|---|
| Weeks 1–2 | 500 mcg | 8 units | 0.08 |
| Weeks 3–4 | 1000 mcg | 15 units | 0.15 |
| Weeks 5–6 | 1500 mcg | 23 units | 0.23 |
| Weeks 7–12 | 2000 mcg | 30 units | 0.30 |
Note: At 6.67 mg/mL, “1 unit equals approximately 0.01 mL and delivers roughly 67 micrograms” on U‑100 insulin syringes.
Dosing Strategy
– Start: 500–1000 mcg daily
– Escalation: Increase by ~500 mcg every 1–2 weeks as tolerated
– Target: 1500–2000 mcg daily by weeks 7–12
– Frequency: Once per day via subcutaneous injection
– Duration: 8–12 weeks; may extend to 16 weeks
– Timing: Consistent daily schedule; rotate injection sites
Reconstitution Instructions
1. Clean vial stopper and work area with alcohol; let dry completely
2. Draw 3.0 mL bacteriostatic water into sterile syringe
3. Inject slowly down the vial wall to avoid foaming
4. Gently swirl to dissolve (do not shake vigorously)
5. Label with date and time of reconstitution
6. Refrigerate immediately at 2–8 °C (35.6–46.4 °F)
Supplies Required (per protocol duration)
For 8-Week Program
– Livagen vials: ~4 vials (20 mg each)
– Insulin syringes (U‑100): 56 syringes
– Bacteriostatic water: 12 mL (2 × 10 mL bottles)
– Alcohol swabs: 112 swabs (2 × 100‑count boxes)
For 12-Week Program
– Livagen vials: ~7 vials
– Insulin syringes: 84 syringes
– Bacteriostatic water: 21 mL (3 × 10 mL bottles)
– Alcohol swabs: 168 swabs (2 × 100‑count boxes)
For 16-Week Program
– Livagen vials: ~10 vials
– Insulin syringes: 112 syringes
– Bacteriostatic water: 30 mL (3 × 10 mL bottles)
– Alcohol swabs: 224 swabs (3 × 100‑count boxes)
Injection Technique
– Clean vial stopper and injection site with alcohol swabs; allow to dry
– Pinch a skinfold and insert needle at 45–90° angle into subcutaneous tissue
– Do not aspirate prior to injection
– Inject slowly and steadily; pause briefly before needle withdrawal
– Rotate injection sites regularly (abdomen, thighs, upper arms)
– Site rotation minimizes local irritation and lipohypertrophy development
Proposed Mechanisms
Research indicates Livagen may:
– Activate ribosomal genes and remodel heterochromatin in aging lymphocytes
– Modulate proteolytic enzyme activity, including inhibition of enkephalin‑degrading enzymes
– Influence gastrointestinal enzyme activity patterns
– Affect hepatocyte protein synthesis rhythms in animal/cellular models
Potential Benefits & Considerations
Reported Benefits
– Chromatin de‑condensation in older adult lymphocytes
– Gene expression modulation associated with aging
– Enzyme regulation at the proteolytic level
Side Effects & Precautions
– Occasional mild injection‑site reactions may occur
– Site rotation prevents lipohypertrophy and local irritation
– Use new sterile syringes for each injection
– Dispose of syringes in approved sharps container
– No standardized human dosing established; protocol is educational for research purposes
Important Warnings & Disclaimers
– Research Use Only: This content is intended for therapeutic educational purposes and does not constitute medical advice, diagnosis, or treatment
– Consult qualified healthcare professionals before beginning any research protocol
– All information on DosagePeptide.com is for research and educational purposes only
– Not intended to diagnose, treat, cure, or prevent any disease
– Store and handle according to applicable pharmaceutical guidelines
Storage & Stability
– Reconstituted vials: Refrigerate at 2–8 °C (35.6–46.4 °F) immediately after mixing
– Lyophilized vials: Store frozen within standard healthcare freezer ranges (~−20 °C)
– Allow frozen vials to reach room temperature before opening to minimize condensation uptake
– Label reconstituted vials with date and time for tracking
References
Key scientific literature cited includes work on chromatin activation in aging lymphocytes, peptide-mediated gene expression, digestive enzyme modulation, and subcutaneous injection pharmacology from peer-reviewed journals and clinical guidelines (CDC, USP, WHO).